This weekend, our @UWashOBGYN team came together to celebrate unity through movement for #GynecologicCancerAwarnessMonth We Moved4our patients, Moved4awareness, Moved4you & #Move4Her! Even @DubsUW, the @UW Husky, joined us on this beautiful Sept. Saturday in Seattle! ☀️🌲🐾 Please consider donating to our team, which is raising funds that go directly toward #GynCancer awareness, education, and research 🔗 2023-move4her.raisely.com/t/… @UWMedicine @fredhutch @SwisherLab @SwisherLiz @BarbaraAGoff @heidigraydrezn5 @RenUrban30 @elise_simons @BarbNorquist @GYNCancer @SGO_org @ggardnermd @AngelesSecord @amandanfader @PDesy3375 @BillzamMD @gynoncjnls @LatinxOncology #movethemessage #gyncsm #obgyntwitter #gcam – at Seattle, WA

.@NCCN released survey results last week of 27 NCCN-member institutions IMPORTANT FINDINGS ➡️ 93% of centers are currently experiencing a shortage of #carboplatin & 70% have a similar lack of #cisplatin ➡️100% of respondents are still able to treat pts who need #cisplatin without any delays/claim denials ➡️64% of respondents are able to keep current pts w/ #carboplatin on the regimen ➡️20% of respondents report being able to continue #carboplatin for some but not all pts ➡️Overall, 16% of respondents report treatment delays as a result of needing to re-obtain prior authorization for modified treatment plans, but none have met with outright denials This issue is widespread across many disease types apart from #gyncancer, including #lungcancer, #breastcancer, #prostatecancer, and as well as many #leukemia and #lymphoma types. The survey is telling and does not take into consideration many non-NCCN centers that may be having a more difficult time managing these shortages. Surprisingly, over 55% of NCCN centers are not sure if local legislative offices are aware of these shortages. Let's help change that! @SGO_org has an easy tool to help you write your local offices: sgo.org/take-action/. Help us continue to advocate for our patients by bringing this to the attention of policymakers. NCCN Statment (total # of respondents differs per survey question): nccn.org/home/news/newsdetai… @amandanfader @AngelesSecord @PDesy3375 @US_FDA @HouseCommerce @OncLive @gyncsm @weoncologists @OncoAlert @OncBrothers @AllisonSaizMD @LatinxOncology @ASHPOfficial #gyncsm #medtwitter #onctwitter